Parallel Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$479 Sell
85
-241
-74% -$1.82K ﹤0.01% 3913
2026
Q2
$3.4K Sell
326
-138
-30% -$1.54K ﹤0.01% 3360
2026
Q1
$5.52K Buy
464
+142
+44% +$1.45K ﹤0.01% 2997
2025
Q4
$3.21K Sell
322
-296
-48% -$2.83K ﹤0.01% 2994
2025
Q3
$5.53K Buy
618
+296
+92% +$2.74K ﹤0.01% 2739
2025
Q2
$3.04K Buy
+322
New +$2.84K ﹤0.01% 2918
2025
Q1
– Sell
-63
Closed -$600 – 3509
2024
Q4
$600 Buy
63
+9
+17% +$91 ﹤0.01% 3193
2024
Q3
$606 Buy
+54
New +$574 ﹤0.01% 3151
2024
Q1
– Sell
-28
Closed -$204 – 3295
2023
Q4
$204 Buy
+28
New +$221 ﹤0.01% 3165
2022
Q4
– Sell
-6
Closed – – 3348
2022
Q3
$0 Buy
+6
New +$123 ﹤0.01% 3114
2021
Q4
– Sell
-184
Closed -$4K – 3052
2021
Q3
$4K Buy
+184
New +$4.45K ﹤0.01% 2424

Other funds holding AHCO

Parallel Advisors's AHCO Position: Q3 2026 in Review

Parallel Advisors reduced its AdaptHealth (AHCO) stake by 74% in Q3 2026, selling an estimated $1.82K and leaving 85 shares worth $479. The position accounts for ﹤0.01% of the portfolio, ranked #3913.

Parallel Advisors first reported a position in AHCO in Q3 2021 and has held it in 11 quarters since. The position peaked at $5.53K in Q3 2025. 61 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.

  • Parallel Advisors held 85 shares of AdaptHealth worth $479 as of Q3 2026.
  • Parallel Advisors sold 241 AdaptHealth shares in Q3 2026, an estimated $1.82K.
  • AdaptHealth made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3913 holding.
  • Parallel Advisors first reported a position in AdaptHealth in Q3 2021 and has held it in 11 quarters since.
  • Parallel Advisors's AdaptHealth position peaked at $5.53K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.